Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

CLBT - Cellebrite DI Ltd. Financial Statements | Finranks

Home

/

CLBT

C

Cellebrite DI Ltd. (CLBT)

NMS – Real Time Price. Currency in USD

15.40

-0.63 (-3.90%)

Market open: Aug 12, 2026, 12:42 PM EDT

15.81

-0.22 (-1.37%)

Previous after-hours: Aug 11, 2026, 7:51 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

476M

401M

325M

271M

Cost of goods sold

-75M

-63M

-53M

-51M

Gross Profit

401M

339M

272M

220M

Operating expenses (excl. COGS)

-330M

-281M

-239M

-217M

Operating Income

71M

57M

33M

3M

Non-operating income, total

20M

-333M

-109M

118M

Pretax income

91M

-276M

-76M

121M

Equity in earnings

0

0

0

0

Taxes

-12M

-7M

-6M

45K

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

-513K

0

0

-5M

Net income before discontinued operations

78M

-283M

-81M

116M

Discontinued operations

0

0

0

0

Net income

78M

-283M

-81M

116M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

939M+34.8%

697M+28.9%

540M+32.2%

409M

Total current assets

569M

562M

417M

290M

Total non-current assets

370M

135M

124M

119M

Total liabilities

455M+26.1%

361M-28.8%

506M+51.1%

335M

Total current liabilities

370M

296M

254M

208M

Total non-current liabilities

85M

65M

252M

127M

Total equity

484M

336M

34M

74M

Total liabilities & shareholders' equities

939M

697M

540M

409M

Total debt

23M+106.7%

11M-22.4%

14M-8.0%

15M

Name

2025

2024

2023

2022

Cash from operating activities

174M

132M

102M

21M

Cash from investing activities

-268M

-149M

-23M

-91M

Cash from financing activities

25M

21M

22M

14M

Free cash flow

160M+29.7%

124M+27.7%

97M+607.8%

14M